Downregulation of amphiregulin improves cardiac hypertrophy via attenuating oxidative stress and apoptosis

Amphiregulin (AREG) is a ligand of epidermal growth factor receptor and participates in the fibrosis of multiple organs. However, whether AREG can regulate hypertrophic cardiomyopathy is not well known. This research aims to explore the effect of AREG on cardiac hypertrophy, and whether the oxidativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Mingyue, Liu, Yun, Zuo, Zhi, Xu, Cheng, Lin, Li, Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394079/
https://www.ncbi.nlm.nih.gov/pubmed/35996142
http://dx.doi.org/10.1186/s13062-022-00334-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394079/
https://www.ncbi.nlm.nih.gov/pubmed/35996142
http://dx.doi.org/10.1186/s13062-022-00334-w

Ejemplares similares